Mogo to Announce Q4 and Fiscal 2023 Financial Results March 20, 2024
VANCOUVER, British Columbia–(BUSINESS WIRE)–Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) (“Mogo” or the “Company”), a digital wealth... Read more.
Global and China Two-wheeler Intelligence and Industry Chain Research Report 2023 Featuring 11 Motorcycle Companies, 10 E2W Companies and 20 Two-wheeler Intelligent Industry Chain Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Two-wheeler Intelligence and Industry Chain Research Report, 2023” report has been added to ResearchAndMarkets.com’s... Read more.
Overseas Shipholding Group Reports Fourth Quarter and Full Year 2023 Results
TAMPA, Fla.–(BUSINESS WIRE)–Overseas Shipholding Group, Inc. (NYSE: OSG) (the “Company” or “OSG”), a leading provider of... Read more.
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
Webcast to be held Monday, March 18th, 4:30 p.m. ET, register for the webcast here, or at the link provided below. DALLAS–(BUSINESS WIRE)–Lantern... Read more.
Armstrong World Industries to Attend the 2024 Loop Investor Conference
LANCASTER, Pa.–(BUSINESS WIRE)–Armstrong World Industries, Inc. (NYSE:AWI), a leader in the design, innovation and manufacture of ceiling and wall solutions,... Read more.
Vecima Unveils Entra® vCMTS for Next-Gen Broadband Access
Entra® vCMTS is part of Vecima’s Entra Cloud™ platform of open, interoperable, cloud-native applications Built to support DOCSIS® 4.0 &... Read more.
Redwire to Present at 36th Annual ROTH Conference on March 18, 2024
JACKSONVILLE, Fla.–(BUSINESS WIRE)–$RDW–Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy,... Read more.
Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs
Late-breaking oral presentation of a subgroup analysis in RAMP 201 Part A heavily pretreated patients receiving avutometinib and defactinib and their best response... Read more.
As Opill Enhances Women’s Reproductive Choices Dr. Mary Jane Minkin Highlights Key Differences Between the Progesterone-Only Opill and Traditional Estrogen-Based Contraceptives “The Pill”
NEW YORK–(BUSINESS WIRE)–The Perrigo launch of their FDA approved OTC Opill is great news for women in the U.S. who rely on progesterone-only... Read more.
Investcorp Europe Acquisition Corp I Amends Business Combination Agreement Following Divestiture of OpSec Security
OpSec Security to be acquired by Crane NXT for $270 million and Zacco to become stand-alone business Investcorp Europe’s Board of Directors evaluating amended... Read more.